NexImmune, Inc. NEXI
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow NEXI
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|
Current Ratio |
— | 4.11 | 3.65 | 0.31 | 11.96 | 3.62 | 1.06 |
Net Debt/EBITDA |
— | (1.76) | 0.50 | (0.51) | 1.56 | 0.55 | 0.10 |
Debt/Assets |
0.00% | 247.82% | 0.00% | 169.17% | 0.00% | 1.39% | 0.00% |
Debt/Equity |
— | (1.45) | 0.00 | (0.28) | 0.00 | 0.02 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.75 | 0.84 | 0.80 | 0.89 | 0.82 | 0.97 |
Capex/Depreciation |
— | 0.00 | (2.85) | (1.40) | (2.70) | (1.18) | (0.04) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 44.33% | 69.02% | 58.99% | (712.92%) | (107.71%) | (180.64%) | |
| — | (210.81%) | (166.59%) | (264.97%) | (100.22%) | (93.23%) | (125.24%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (1,775.29%) | 0.00% | (7,175.66%) |
Return on Tangible Assets |
— | (135.19%) | (219.15%) | 210.47% | (61.42%) | (198.47%) | (1,937.14%) |
Average Days of Receivables |
— | — | — | — | — | 0.00 | — |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | (12.34) | (416.56) | (543.22) | (59.62) | (54.41) | (29.99) |
Cash per Share |
— | 13.39 | 205.71 | 101.57 | 101.42 | 36.05 | 3.07 |
Shareholders Equity per Share |
— | (26.90) | (867.13) | (1,381.97) | 103.74 | 33.56 | 3.34 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (26.90) | (867.13) | (1,381.97) | 103.74 | 33.56 | 3.34 |
Free Cash Flow |
— | (11.12) | (20.66) | (27.27) | (48.14) | (52.37) | (31.47) |
Working Capital |
— | 9.33 | 8.01 | (18.63) | 79.06 | 27.04 | 0.32 |
Capital Expenditures |
— | (0.94) | (1.25) | (0.86) | (2.35) | (1.17) | (0.04) |
Net Current Asset Value |
— | (26.05) | (45.69) | (72.28) | 79.01 | 26.61 | 0.32 |
| Other line items | |||||||
Quick Ratio |
— | 4.02 | 3.37 | 0.19 | 11.35 | 3.36 | 0.63 |
Depreciation/Fixed assets |
— | 0.12 | 0.17 | 0.21 | 0.20 | 0.22 | 0.76 |
Cash ROIC |
— | (56.03%) | 67.04% | 64.86% | (30.31%) | (82.33%) | (486.96%) |
Accounts Payable Turnover |
— | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
— | 1,535.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (12.34) | (391.44) | (525.99) | (56.71) | (53.19) | (29.95) |
Capex per Share |
— | 0.00 | (25.12) | (17.23) | (2.91) | (1.22) | (0.04) |
Average Payables |
— | 1.02 | 1.02 | 1.97 | 1.90 | 1.71 | 1.86 |
Average Assets |
— | 7.07 | 13.93 | 12.51 | 51.17 | 67.05 | 25.83 |
Average Common Equity |
— | (33.62) | (33.62) | (56.19) | 7.19 | 58.03 | 17.91 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates